APA (7th ed.) Citation

Herman, D., Locatelli, I., Grabnar, I., Peternel, P., Stegnar, M., Mrhar, A., . . . Dolzan, V. (2005). Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose. Pharmacogenomics Journal, 5(3), 193. https://doi.org/10.1038/sj.tpj.6500308

Chicago Style (17th ed.) Citation

Herman, D., I. Locatelli, I. Grabnar, P. Peternel, M. Stegnar, A. Mrhar, K. Breskvar, and V. Dolzan. "Influence of CYP2C9 Polymorphisms, Demographic Factors and Concomitant Drug Therapy on Warfarin Metabolism and Maintenance Dose." Pharmacogenomics Journal 5, no. 3 (2005): 193. https://doi.org/10.1038/sj.tpj.6500308.

MLA (9th ed.) Citation

Herman, D., et al. "Influence of CYP2C9 Polymorphisms, Demographic Factors and Concomitant Drug Therapy on Warfarin Metabolism and Maintenance Dose." Pharmacogenomics Journal, vol. 5, no. 3, 2005, p. 193, https://doi.org/10.1038/sj.tpj.6500308.